Concepedia
Statistics
Publications
40
Citations
3.5K
H-Index
31
Active since
1996
Affiliations
Benaroya Research Institute(Current)
University of Washington
University of California, San Francisco
Virginia Mason Medical Center
Immune Tolerance Network
Srinath Sanda is an author at Benaroya Research Institute specializing in life sciences, immunology, and diabetes mellitus.
Publications per year
1996–2024
Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials
Antoinette Moran, Brian N. Bundy, Dorothy Becker et al. · The Lancet · 2013 · 354 citations · Full text
Medicine, Endocrinology, Immunology +14
Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs β-Cell Function
S. Alice Long, Mary Rieck, Srinath Sanda et al. · Diabetes · 2012 · 310 citations · Full text
Life Sciences, Endocrinology, Immunology +17
Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1
Jenny E. Kanter, Farah Kramer, Shelley Barnhart et al. · Proceedings of the National Academy of Sciences · 2012 · 308 citations · Full text
Life Sciences, Biochemistry, Immunology +17
The Effector T Cells of Diabetic Subjects Are Resistant to Regulation via CD4+FOXP3+ Regulatory T Cells
Anya Schneider, Mary Rieck, Srinath Sanda et al. · The Journal of Immunology · 2008 · 297 citations · Full text
Life Sciences, Cell Biology, Immunology +15
Defects in IL-2R Signaling Contribute to Diminished Maintenance of FOXP3 Expression in CD4+CD25+ Regulatory T-Cells of Type 1 Diabetic Subjects
S. Alice Long, Karen Cerosaletti, Paul L. Bollyky et al. · Diabetes · 2009 · 279 citations · Full text
Life Sciences, Cell Biology, Immunology +17
1–5 of 40